Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Cancer|Metastatic Breast Cancer|Metastatic Lung Cancer|Solid Tumor|Cancer
Interventions: DRUG: SV-101
Sponsor: Williams Cancer Foundation
Collaborators: Syncromune, Inc.